Antiarrhythmic drug therapy after catheter ablation for atrial fibrillation has no impact on recurrences, cardiovascular events and mortality - insights from the German Ablation Registry

被引：0

作者：

Schleberger, R. ^{[1
]}

Metzner, A. ^{[1
]}

Kuck, K. H. ^{[2
]}

Andresen, D. ^{[3
]}

Willems, S. ^{[4
]}

Hoffmann, E. ^{[5
]}

Deneke, T. ^{[6
]}

Eckardt, L. ^{[7
]}

Brachmann, J. ^{[8
]}

Hochadel, M. ^{[9
]}

Senges, J. ^{[9
]}

Rillig, A. ^{[1
]}

机构：

[1] Univ Heart & Vasc Ctr Hamburg, Hamburg, Germany

[2] LANS Cardio, Hamburg, Germany

[3] Hubertus Hosp, Berlin, Germany

[4] Asklepios Clin St Georg, Hamburg, Germany

[5] Clin Bogenhausen, Munich, Germany

[6] Heart Ctr Bad Neustadt, Bad Neustadt an der Saale, Germany

[7] Muenster Univ Hosp, Munster, Germany

[8] Hosp Coburg, Coburg, Germany

[9] Stiftung Inst Herzinfarktforsch, Ludwigshafen, Germany

来源：

EUROPEAN HEART JOURNAL | 2021年 / 42卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：357 / 357

页数：1

共 50 条

[21] Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry
Usuda, Keisuke
Kato, Takeshi
Tsuda, Toyonobu
Tada, Hayato
Niwa, Satoru
Usui, Soichiro
Sakata, Kenji
Hayashi, Kenshi
Furusho, Hiroshi
Kawashiri, Masaaki
Takamura, Masayuki
Otsuka, Takayuki
Suzuki, Shinya
Hirata, Akio
Murakami, Masato
Takami, Mitsuru
Kimura, Masaomi
Fukaya, Hidehira
Nakahara, Shiro
Shimizu, Wataru
Iwasaki, Yu-ki
Hayashi, Hiroshi
Harada, Tomoo
Nakajima, Ikutaro
Okumura, Ken
Koyama, Junjiroh
Tokuda, Michifumi
Yamane, Teiichi
Momiyama, Yukihiko
Tanimoto, Kojiro
Soejima, Kyoko
Nonoguchi, Noriko
Ejima, Koichiro
Hagiwara, Nobuhisa
Harada, Masahide
Sonoda, Kazumasa
Inoue, Masaru
Kumagai, Koji
Hayashi, Hidemori
Satomi, Kazuhiro
Yazaki, Yoshinao
Watari, Yuji
Arai, Masaru
Watanabe, Ryuta
Yokoyama, Katsuaki
Matsumoto, Naoya
Nagashima, Koichi
Okumura, Yasuo
HEART AND VESSELS, 2022, 37 (02) : 327 - 336
[22] Impact of sinus rhythm maintenance on major adverse cardiac and cerebrovascular events after catheter ablation of atrial fibrillation: insights from AF frontier ablation registry
Keisuke Usuda
Takeshi Kato
Toyonobu Tsuda
Hayato Tada
Satoru Niwa
Soichiro Usui
Kenji Sakata
Kenshi Hayashi
Hiroshi Furusho
Masaaki Kawashiri
Masayuki Takamura
Takayuki Otsuka
Shinya Suzuki
Akio Hirata
Masato Murakami
Mitsuru Takami
Masaomi Kimura
Hidehira Fukaya
Shiro Nakahara
Wataru Shimizu
Yu-ki Iwasaki
Hiroshi Hayashi
Tomoo Harada
Ikutaro Nakajima
Ken Okumura
Junjiroh Koyama
Michifumi Tokuda
Teiichi Yamane
Yukihiko Momiyama
Kojiro Tanimoto
Kyoko Soejima
Noriko Nonoguchi
Koichiro Ejima
Nobuhisa Hagiwara
Masahide Harada
Kazumasa Sonoda
Masaru Inoue
Koji Kumagai
Hidemori Hayashi
Kazuhiro Satomi
Yoshinao Yazaki
Yuji Watari
Masaru Arai
Ryuta Watanabe
Katsuaki Yokoyama
Naoya Matsumoto
Koichi Nagashima
Yasuo Okumura
Heart and Vessels, 2022, 37 : 327 - 336
[23] Comparing ablation and antiarrhythmic drug therapy for atrial fibrillation
David J. Callans
Current Cardiology Reports, 2009, 11 (5) : 321 - 322
[24] Anticoagulation in high thromboembolic risk after catheter ablation for atrial fibrillation: Results from the German Ablation Registry
Moser, J.
Kuck, K. H.
Andresen, D.
Spitzer, S. G.
Hoffmann, E.
Schumacher, B.
Eckardt, L.
Brachmann, J.
Lewalter, T.
Hochadel, M.
Senges, J.
Willems, S.
Hoffmann, B. A.
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (39) : 1923 - 1928
[25] Catheter ablation of drug induced atrial flutter:: impact on atrial fibrillation recurrences and quality of life
Bielik, H
Schrickel, J
Shlevkov, N
Yang, A
Schwab, JO
Schimpf, R
Lüderitz, B
Lewalter, T
EUROPEAN HEART JOURNAL, 2002, 23 : 658 - 658
[26] Clinical outcome of catheter ablation for persistent atrial fibrillation which acts as paroxysmal atrial fibrillation after antiarrhythmic drug therapy
Chun, K. J.
Hwang, J. K.
Park, S. J.
Park, K. M.
Kim, J. S.
On, Y. K.
EUROPEAN HEART JOURNAL, 2016, 37 : 1087 - 1087
[27] Antikoagulation und Antiarrhythmika nach VorhofflimmerablationAnticoagulation and antiarrhythmic drug therapy after catheter ablation of atrial fibrillation
H. Volkmann
C. Bergmann
M. Walter
Clinical Research in Cardiology Supplements, 2008, 3 (1) : 118 - 123
[28] The impact of basic atrial rhythm during catheter ablation of atrial fibrillation on clinical outcomes: Lessons from the German Ablation Registry
Rottner, Laura
Brachmann, Johannes
Lewalter, Thorsten
Kuck, Karl-Heinz
Willems, Stephan
Eckardt, Lars
Hochadel, Matthias
Andresen, Dietrich
Senges, Jochen
Rillig, Andreas
Metzner, Andreas
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2021, 32 (07) : 1833 - 1841
[29] Antiarrhythmic drug therapy and all-cause mortality after catheter ablation of atrial fibrillation: A propensity-matched analysis
Shantha, Ghanshyam
Alyesh, Daniel
Ghanbari, Hamid
Yokokawa, Miki
Saeed, Mohammed
Cunnane, Ryan
Latchamsetty, Rakesh
Crawford, Thomas
Jongnarangsin, Krit
Bogun, Frank
Pelosi, Frank, Jr.
Chugh, Aman
Morady, Fred
Oral, Hakan
HEART RHYTHM, 2019, 16 (09) : 1368 - 1373
[30] Mortality after catheter ablation for atrial fibrillation compared with antiarrhythmic drug therapy. A meta-analysis of randomized trials
Dagres, Nikolaos
Varounis, Christos
Flevari, Panayota
Piorkowski, Christopher
Bode, Kerstin
Rallidis, Loukianos S.
Tsougos, Elias
Leftheriotis, Dionyssios
Sommer, Philipp
Hindricks, Gerhard
Kremastinos, Dimitrios Th.
AMERICAN HEART JOURNAL, 2009, 158 (01) : 15 - 20

← 1 2 3 4 5 →